2024-11-01 2025-10-31 2025-10-31 false 11600671 HIGHLAND MEDICO-LEGAL LTD 2025-11-19 false iso4217:GBP xbrli:pure 11600671 2024-10-31 11600671 2025-10-31 11600671 2024-11-01 2025-10-31 11600671 2023-10-31 11600671 2024-10-31 11600671 2023-11-01 2024-10-31 11600671 bus:SmallEntities 2024-11-01 2025-10-31 11600671 bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 11600671 bus:AbridgedAccounts 2024-11-01 2025-10-31 11600671 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 11600671 core:WithinOneYear 2025-10-31 11600671 core:AfterOneYear 2025-10-31 11600671 core:WithinOneYear 2024-10-31 11600671 core:AfterOneYear 2024-10-31 11600671 core:ShareCapital 2025-10-31 11600671 core:SharePremium 2025-10-31 11600671 core:RevaluationReserve 2025-10-31 11600671 core:OtherReservesSubtotal 2025-10-31 11600671 core:RetainedEarningsAccumulatedLosses 2025-10-31 11600671 core:ShareCapital 2024-10-31 11600671 core:SharePremium 2024-10-31 11600671 core:RevaluationReserve 2024-10-31 11600671 core:OtherReservesSubtotal 2024-10-31 11600671 core:RetainedEarningsAccumulatedLosses 2024-10-31 11600671 core:LandBuildings 2025-10-31 11600671 core:PlantMachinery 2025-10-31 11600671 core:Vehicles 2025-10-31 11600671 core:FurnitureFittings 2025-10-31 11600671 core:OfficeEquipment 2025-10-31 11600671 core:NetGoodwill 2025-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2025-10-31 11600671 core:ListedExchangeTraded 2025-10-31 11600671 core:UnlistedNon-exchangeTraded 2025-10-31 11600671 core:LandBuildings 2024-10-31 11600671 core:PlantMachinery 2024-10-31 11600671 core:Vehicles 2024-10-31 11600671 core:FurnitureFittings 2024-10-31 11600671 core:OfficeEquipment 2024-10-31 11600671 core:NetGoodwill 2024-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2024-10-31 11600671 core:ListedExchangeTraded 2024-10-31 11600671 core:UnlistedNon-exchangeTraded 2024-10-31 11600671 core:LandBuildings 2024-11-01 2025-10-31 11600671 core:PlantMachinery 2024-11-01 2025-10-31 11600671 core:Vehicles 2024-11-01 2025-10-31 11600671 core:FurnitureFittings 2024-11-01 2025-10-31 11600671 core:OfficeEquipment 2024-11-01 2025-10-31 11600671 core:NetGoodwill 2024-11-01 2025-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2024-11-01 2025-10-31 11600671 core:ListedExchangeTraded 2024-11-01 2025-10-31 11600671 core:UnlistedNon-exchangeTraded 2024-11-01 2025-10-31 11600671 core:MoreThanFiveYears 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments 2025-10-31 11600671 core:Non-currentFinancialInstruments 2024-10-31 11600671 dpl:CostSales 2024-11-01 2025-10-31 11600671 dpl:DistributionCosts 2024-11-01 2025-10-31 11600671 core:LandBuildings 2024-11-01 2025-10-31 11600671 core:PlantMachinery 2024-11-01 2025-10-31 11600671 core:Vehicles 2024-11-01 2025-10-31 11600671 core:FurnitureFittings 2024-11-01 2025-10-31 11600671 core:OfficeEquipment 2024-11-01 2025-10-31 11600671 dpl:AdministrativeExpenses 2024-11-01 2025-10-31 11600671 core:NetGoodwill 2024-11-01 2025-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2024-11-01 2025-10-31 11600671 dpl:GroupUndertakings 2024-11-01 2025-10-31 11600671 dpl:ParticipatingInterests 2024-11-01 2025-10-31 11600671 dpl:GroupUndertakings core:ListedExchangeTraded 2024-11-01 2025-10-31 11600671 core:ListedExchangeTraded 2024-11-01 2025-10-31 11600671 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-11-01 2025-10-31 11600671 core:UnlistedNon-exchangeTraded 2024-11-01 2025-10-31 11600671 dpl:CostSales 2023-11-01 2024-10-31 11600671 dpl:DistributionCosts 2023-11-01 2024-10-31 11600671 core:LandBuildings 2023-11-01 2024-10-31 11600671 core:PlantMachinery 2023-11-01 2024-10-31 11600671 core:Vehicles 2023-11-01 2024-10-31 11600671 core:FurnitureFittings 2023-11-01 2024-10-31 11600671 core:OfficeEquipment 2023-11-01 2024-10-31 11600671 dpl:AdministrativeExpenses 2023-11-01 2024-10-31 11600671 core:NetGoodwill 2023-11-01 2024-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2023-11-01 2024-10-31 11600671 dpl:GroupUndertakings 2023-11-01 2024-10-31 11600671 dpl:ParticipatingInterests 2023-11-01 2024-10-31 11600671 dpl:GroupUndertakings core:ListedExchangeTraded 2023-11-01 2024-10-31 11600671 core:ListedExchangeTraded 2023-11-01 2024-10-31 11600671 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-11-01 2024-10-31 11600671 core:UnlistedNon-exchangeTraded 2023-11-01 2024-10-31 11600671 core:NetGoodwill 2025-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2025-10-31 11600671 core:LandBuildings 2025-10-31 11600671 core:PlantMachinery 2025-10-31 11600671 core:Vehicles 2025-10-31 11600671 core:FurnitureFittings 2025-10-31 11600671 core:OfficeEquipment 2025-10-31 11600671 core:AfterOneYear 2025-10-31 11600671 core:WithinOneYear 2025-10-31 11600671 core:ListedExchangeTraded 2025-10-31 11600671 core:UnlistedNon-exchangeTraded 2025-10-31 11600671 core:ShareCapital 2025-10-31 11600671 core:SharePremium 2025-10-31 11600671 core:RevaluationReserve 2025-10-31 11600671 core:OtherReservesSubtotal 2025-10-31 11600671 core:RetainedEarningsAccumulatedLosses 2025-10-31 11600671 core:NetGoodwill 2024-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2024-10-31 11600671 core:LandBuildings 2024-10-31 11600671 core:PlantMachinery 2024-10-31 11600671 core:Vehicles 2024-10-31 11600671 core:FurnitureFittings 2024-10-31 11600671 core:OfficeEquipment 2024-10-31 11600671 core:AfterOneYear 2024-10-31 11600671 core:WithinOneYear 2024-10-31 11600671 core:ListedExchangeTraded 2024-10-31 11600671 core:UnlistedNon-exchangeTraded 2024-10-31 11600671 core:ShareCapital 2024-10-31 11600671 core:SharePremium 2024-10-31 11600671 core:RevaluationReserve 2024-10-31 11600671 core:OtherReservesSubtotal 2024-10-31 11600671 core:RetainedEarningsAccumulatedLosses 2024-10-31 11600671 core:NetGoodwill 2023-10-31 11600671 core:IntangibleAssetsOtherThanGoodwill 2023-10-31 11600671 core:LandBuildings 2023-10-31 11600671 core:PlantMachinery 2023-10-31 11600671 core:Vehicles 2023-10-31 11600671 core:FurnitureFittings 2023-10-31 11600671 core:OfficeEquipment 2023-10-31 11600671 core:AfterOneYear 2023-10-31 11600671 core:WithinOneYear 2023-10-31 11600671 core:ListedExchangeTraded 2023-10-31 11600671 core:UnlistedNon-exchangeTraded 2023-10-31 11600671 core:ShareCapital 2023-10-31 11600671 core:SharePremium 2023-10-31 11600671 core:RevaluationReserve 2023-10-31 11600671 core:OtherReservesSubtotal 2023-10-31 11600671 core:RetainedEarningsAccumulatedLosses 2023-10-31 11600671 core:AfterOneYear 2024-11-01 2025-10-31 11600671 core:WithinOneYear 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:CostValuation 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-11-01 2025-10-31 11600671 core:Non-currentFinancialInstruments core:CostValuation 2025-10-31 11600671 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-10-31 11600671 core:Non-currentFinancialInstruments core:CostValuation 2024-10-31 11600671 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-10-31 11600671 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-10-31 11600671 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-10-31 11600671 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-10-31 11600671 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-10-31 11600671 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-10-31 11600671 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-10-31 11600671 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-10-31 11600671 bus:Director1 2024-11-01 2025-10-31 11600671 bus:Director2 2024-11-01 2025-10-31 11600671 bus:Director3 2024-11-01 2025-10-31

HIGHLAND MEDICO-LEGAL LTD

Registered Number
11600671
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

HIGHLAND MEDICO-LEGAL LTD
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors | Mr R P Coggins
| Mrs S I Coggins
| Mr T Coggins

Registered Address | 23 Woodland Road
| Darlington
| DL3 7BJ

Registered Number | 11600671 (England and Wales)

HIGHLAND MEDICO-LEGAL LTD
Statement of Financial Position
31 October 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 2,691 |  |  |  | 2,939
|  |  |  | 2,691 |  |  |  | 2,939
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 140,400 |  |  |  | 118,000 |  |
Cash at bank and on hand |  | 39,244 |  |  |  | 21,922 |  |
|  | 179,644 |  |  |  | 139,922 |  |
Creditors amounts falling due within one year | 5 | (13,813) |  |  |  | (10,690) |  |
Net current assets (liabilities) |  |  |  | 165,831 |  |  |  | 129,232
Total assets less current liabilities |  |  |  | 168,522 |  |  |  | 132,171
Net assets |  |  |  | 168,522 |  |  |  | 132,171
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 2 |  |  |  | 2
Profit and loss account |  |  |  | 168,520 |  |  |  | 132,169
Shareholders' funds |  |  |  | 168,522 |  |  |  | 132,171

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
- The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 19 November 2025, and are signed on its behalf by:
Mr R P Coggins Director Registered Company No. 11600671

HIGHLAND MEDICO-LEGAL LTD
Notes to the Financial Statements
for the year ended 31 October 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Revenue from sale of goods
--- | ---
| Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

| Current taxation
--- | ---
| Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Reducing balance (%)
| Office Equipment | 33

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 3 |  | 3

3. | Tangible fixed assets
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 November 24 | 6,494
| Additions | 1,078
| At 31 October 25 | 7,572
| Depreciation and impairment
| At 01 November 24 | 3,555
| Charge for year | 1,326
| At 31 October 25 | 4,881
| Net book value
| At 31 October 25 | 2,691
| At 31 October 24 | 2,939

4. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other debtors | 140,400 |  | 118,000
| Total | 140,400 |  | 118,000

5. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 13,331 |  | 9,217
| Other creditors | 482 |  | 736
| Accrued liabilities and deferred income | - |  | 737
| Total | 13,813 |  | 10,690